Study on IDH-mutant tumor cells in brain tumors
Part of Cancer clinical trials.
This study looks at leftover tumor cells in people with a type of brain tumor called IDH-mutant glioma. Doctors want to learn how many tumor cells remain after treatment by testing tissue from a biopsy or surgery. This may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a brain tumor called diffuse glioma that is known to have an IDH mutation.
- You are scheduled to have a biopsy or surgery for your tumor at NYU Langone Health.
- You do not have an active hepatitis C infection or a prion disease (like Creutzfeldt-Jakob disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of PET/MRI scan to look for a common genetic change (IDH mutation) in brain tumors (gliomas). The goal is to improve how doctors diagnose and treat these tumors.
This trial studies whether changes in RNA (the instructions inside cells) can help doctors better diagnose and treat gliomas, a type of brain tumor. If you are scheduled for surgery to remove a suspected glioma and have not had prior treatment, you may be able to join.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This study looks at how different treatments work for people with advanced brain or spinal cord tumors that have come back. It helps doctors learn more about these tumors and how to better treat them.
This study collects information about people in Brazil who have a type of brain tumor called an IDH-mutant glioma, diagnosed in 2021 or after. It aims to learn more about the characteristics and outcomes of these tumors, which may help improve future care.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.